Amundi Asset Management US’s Core Laboratories CLB Stock Holding History

Amundi Asset Management US’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$3.84M	Buy	+133,444	New	+$4.56M	﹤0.01%	1078
2020 Q1	–	Sell	-6,371	Closed	-$240K	–	1608
2019 Q4	$240K	Buy	6,371 +3,880	+156%	+$174K	﹤0.01%	1429
2019 Q3	$116K	Sell	2,491 -3,314	-57%	-$154K	﹤0.01%	1545
2019 Q2	$303K	Buy	+5,805	New	+$340K	﹤0.01%	1417
2018 Q4	–	Sell	-218,446	Closed	-$25.3M	–	1608
2018 Q3	$25.3M	Buy	218,446 +38,700	+22%	+$4.37M	0.03%	479
2018 Q2	$22.7M	Buy	179,746 +28,661	+19%	+$3.49M	0.03%	488
2018 Q1	$16.4M	Buy	151,085 +33,921	+29%	+$3.75M	0.03%	545
2017 Q4	$12.8M	Buy	+117,164	New	+$11.7M	0.02%	606
2016 Q3	–	Sell	-19,415	Closed	-$2.4M	–	546
2016 Q2	$2.4M	Sell	19,415 -14,134	-42%	-$1.71M	0.01%	491
2016 Q1	$3.77M	Hold	33,549	–	–	0.01%	437
2015 Q4	$3.65M	Buy	+33,549	New	+$3.84M	0.01%	449
2015 Q3	–	Sell	-65,877	Closed	-$7.51M	–	592
2015 Q2	$7.51M	Buy	+65,877	New	+$7.99M	0.03%	384

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amundi Asset Management US's CLB Position: Q1 2021 in Review

Amundi Asset Management US opened a new position in Core Laboratories (CLB) in Q1 2021: 133,444 shares worth $3.84M. The stake represents ﹤0.01% of the portfolio and ranks #1078 among its holdings. This is a return to the name: Amundi Asset Management US previously reported a position in CLB as recently as Q4 2019.

Amundi Asset Management US first reported a position in CLB in Q2 2015 and has held it in 12 quarters since. The position peaked at $25.3M in Q3 2018. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

Amundi Asset Management US held 133,444 shares of Core Laboratories worth $3.84M as of Q1 2021.
Core Laboratories was a new Amundi Asset Management US position in Q1 2021.
Core Laboratories made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1078 holding.
Amundi Asset Management US first reported a position in Core Laboratories in Q2 2015 and has held it in 12 quarters since.
Amundi Asset Management US's Core Laboratories position peaked at $25.3M in Q3 2018.
183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.